ENGINEERING HOPE Trademark

Trademark Overview


On Wednesday, September 27, 2023, a trademark application was filed for ENGINEERING HOPE with the United States Patent and Trademark Office. The USPTO has given the ENGINEERING HOPE trademark a serial number of 98199510. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, October 1, 2024. This trademark is owned by Aresnal Bioscienes, Inc.. The ENGINEERING HOPE trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Biotechnology research and development services for others, namely, the detection, treatment and prevention of oncological diseases, disorders and conditions; biotechnology research and development services for others, namely, the detection, treatment and prevention of infectious diseases, disorders and conditions

Medical and scientific research; research and development of biologics for medical use; research and development of immune cell therapies and T-cell preparations for medical use; custom product development of biologics, immune cell therapies and T-cell preparations
engineering hope

General Information


Serial Number98199510
Word MarkENGINEERING HOPE
Filing DateWednesday, September 27, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, October 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2024

Trademark Statements


Goods and ServicesBiotechnology research and development services for others, namely, the detection, treatment and prevention of oncological diseases, disorders and conditions; biotechnology research and development services for others, namely, the detection, treatment and prevention of infectious diseases, disorders and conditions
Goods and ServicesMedical and scientific research; research and development of biologics for medical use; research and development of immune cell therapies and T-cell preparations for medical use; custom product development of biologics, immune cell therapies and T-cell preparations

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 11, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 6, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAresnal Bioscienes, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameAresnal Bioscienes, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Monday, May 27, 2024NON-FINAL ACTION WRITTEN
Saturday, September 30, 2023NEW APPLICATION ENTERED
Wednesday, October 11, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 20, 2024ASSIGNED TO EXAMINER
Thursday, June 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 28, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 6, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 1, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 27, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 27, 2024NON-FINAL ACTION E-MAILED